SAN FRANCISCO, June 5, 2018 /PRNewswire/ -- Nektar
Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief
Scientific Officer, Jonathan Zalevsky, Ph.D., is scheduled to
present at the upcoming Jefferies 2018 Healthcare
Conference in New York City on Wednesday, June 6,
2018 at 3:00 p.m. Eastern Time.
The presentation will be accessible via a Webcast through a link
posted on the Investors, Events Calendar section of the Nektar
website: http://ir.nektar.com/events-and-presentations/events.
This Webcast will be available for replay until July 6,
2018.
About Nektar
Nektar Therapeutics is a
research-based, development stage biopharmaceutical company whose
mission is to discover and develop innovative medicines to address
the unmet medical needs of patients. Our R&D pipeline of new
investigational medicines includes treatments for cancer,
autoimmune disease and chronic pain. We leverage Nektar's
proprietary and proven chemistry platform in the discovery and
design of our new therapeutic candidates. Nektar is headquartered
in San Francisco, California, with additional operations
in Huntsville, Alabama and Hyderabad, India.
Further information about the company and its drug development
programs and capabilities may be found online
at http://www.nektar.com.
Contact:
Investors
Jennifer Ruddock of Nektar Therapeutics
415-482-5585
View original
content:http://www.prnewswire.com/news-releases/nektar-to-webcast-presentation-at-the-jefferies-2018-healthcare-conference-in-new-york-300659672.html
SOURCE Nektar Therapeutics